Codexis, Inc. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount
Codexis, Inc. (CDXS) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of $300.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2026-03-11
- Codexis, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2025-12-31 was $300.00K, a 89.97% decline year-over-year.
- Codexis, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2024-12-31 was $2.99M, a 64.12% decline year-over-year.
- Codexis, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2024-09-30 was $3.90M, a 0.00% change year-over-year.
- Codexis, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2023-12-31 was $8.34M.
- Codexis, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2025 was $300.00K, a 95.65% decline from fiscal 2024.
- Codexis, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2024 was $6.90M, a 43.50% decline from fiscal 2023.
- Codexis, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2023 was $12.21M.
- Codexis, Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2022 was $0.00.
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 6 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 9 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month |
|---|---|---|---|---|
| 2025-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $300.00K 10-K · filed 2026-03-11 | ||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | |||
| 2024-12-31 | $2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $6.89M derived: sum of 2 quarters · filed 2026-03-11 | $6.90M 10-K · filed 2026-03-11 | |
| 2024-09-30 | $3.90M 10-Q · filed 2025-11-06 | $3.91M 10-Q · filed 2025-11-06 | ||
| 2023-12-31 | $8.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $12.24M derived: sum of 2 quarters · filed 2026-03-11 | $12.21M 10-K · filed 2026-03-11 | |
| 2023-09-30 | $3.90M 10-Q · filed 2024-10-31 | $3.88M 10-Q · filed 2024-10-31 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-03 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| XCF Global, Inc. (SAFX) | United States | $0.171B | -2.86 |
| AEMETIS, INC (AMTX) | United States | $0.128B | -1.95 |
| Comstock Inc. (LODE) | United States | $0.195B | -5.19 |
| LanzaTech Global, Inc. (LNZA) | United States | $0.078B | 0.52 |
| FutureFuel Corp. (FF) | United States | $0.225B | -6.53 |
| Alto Ingredients, Inc. (ALTO) | United States | $0.289B | 8.52 |
| TOMI Environmental Solutions, Inc. (TOMZ) | United States | $0.012B | |
| Gevo, Inc. (GEVO) | United States | $0.345B | -1.72 |
| Westlake Chemical Partners LP (WLKP) | United States | $0.754B | 2.35 |
| Green Plains Inc. (GPRE) | United States | $1.054B | 8.70 |